Ireland
Medical device market intelligence for Ireland. Regulatory changes, competitor moves, and procurement trends.
Recent signals
AP Technologies acquires Blueacre Technology to enhance its European operations and catheter platform.
Medtronic is establishing a European software hub in Ireland, creating 85 jobs in cardiac digital health.
AbbVie Inc. has registered a medical device with product code KNT in the FDA database.
Medtronic is restructuring its cardiovascular business and closing its Santa Rosa facility, impacting 370 employees.
Perfuze is developing a novel stroke aspiration device, facing challenges and opportunities in the medical device market.
Abbott Laboratories has registered three medical devices under product code QBJ with the FDA.
Tcoag Ireland Limited has FDA registration 3008386529 for a product under code DAP.
The Baska mask, a new supraglottic airway device, has been assessed against the LMA in a completed study.
A completed UK & Ireland audit assessed MS patient adherence to Rebif® injections using the RebiSmart™ device.
A completed study assessed compliance and satisfaction with the Lenire bimodal stimulation device for tinnitus treatment.
Over half of women with gestational diabetes face harmful stigma affecting their well-being, according to new research.
The PhenMap tool predicts bowel cancer patients' responses to a new NHS drug, potentially sparing ineffective treatments.
Manna, an Irish drone delivery startup, secured $50M to expand operations in the U.S. and Europe, totaling $110M funding.
The ATTUNE KNEE SYSTEM by DePuy Ireland UC is classified as a Class I medical device.
The ATTUNE KNEE SYSTEM by DePuy Ireland UC is classified as Class I and registered with UDI-DI 10603295505051.
The ATTUNE device by DePuy Ireland UC is classified as Class IIB and registered with UDI-DI 10603295520801.
Omni raised $120 million to address enterprise data translation issues, valued at $1.51 billion post-funding.
The Windsor Framework outlines pharmacovigilance protocols for medical devices post-agreement.
Iterum Therapeutics is winding down due to limited cash and poor sales of its antibiotic Orlynvah.
WHO's first Global Forum unites over 800 Collaborating Centres to enhance scientific collaboration for public health.